https://www.healio.com/news/hematology-oncology/20220909/metabolic-imaging-predicts-neoadjuvant-therapy-response-before-pancreatic-cancer-surgery
The addition of 18-fluorodeoxyglucose to PET provided significant prognostic benefit in objective assessment of neoadjuvant chemotherapy response among patients with borderline resectable/locally advanced pancreatic cancer.The findings, published in JNCCN &md…
Create an account or login to join the discussion